1. Home
  2. ARTL vs WTO Comparison

ARTL vs WTO Comparison

Compare ARTL & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • WTO
  • Stock Information
  • Founded
  • ARTL 2011
  • WTO 2008
  • Country
  • ARTL United States
  • WTO China
  • Employees
  • ARTL N/A
  • WTO N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • WTO Consumer Electronics/Appliances
  • Sector
  • ARTL Health Care
  • WTO Technology
  • Exchange
  • ARTL Nasdaq
  • WTO Nasdaq
  • Market Cap
  • ARTL 3.1M
  • WTO 3.3M
  • IPO Year
  • ARTL N/A
  • WTO 2021
  • Fundamental
  • Price
  • ARTL $9.35
  • WTO $0.94
  • Analyst Decision
  • ARTL Strong Buy
  • WTO
  • Analyst Count
  • ARTL 2
  • WTO 0
  • Target Price
  • ARTL $24.00
  • WTO N/A
  • AVG Volume (30 Days)
  • ARTL 124.7K
  • WTO 41.2K
  • Earning Date
  • ARTL 08-13-2025
  • WTO 08-11-2025
  • Dividend Yield
  • ARTL N/A
  • WTO N/A
  • EPS Growth
  • ARTL N/A
  • WTO N/A
  • EPS
  • ARTL N/A
  • WTO N/A
  • Revenue
  • ARTL N/A
  • WTO $34,589,265.00
  • Revenue This Year
  • ARTL N/A
  • WTO N/A
  • Revenue Next Year
  • ARTL N/A
  • WTO N/A
  • P/E Ratio
  • ARTL N/A
  • WTO N/A
  • Revenue Growth
  • ARTL N/A
  • WTO 54.01
  • 52 Week Low
  • ARTL $4.92
  • WTO $0.75
  • 52 Week High
  • ARTL $28.60
  • WTO $622.50
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 41.84
  • WTO 41.60
  • Support Level
  • ARTL $9.16
  • WTO $0.84
  • Resistance Level
  • ARTL $10.55
  • WTO $1.10
  • Average True Range (ATR)
  • ARTL 0.76
  • WTO 0.10
  • MACD
  • ARTL -0.04
  • WTO -0.02
  • Stochastic Oscillator
  • ARTL 48.94
  • WTO 41.46

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks: